Aerpio Therapeutics
Biotechnology company, develops new small molecules and monoclonal antibodies for the treatment of vascular diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$88—132m (Dealroom.co estimates Apr 2014.)
Share price
$27.92
Cincinnati Ohio (HQ)
Authorizing premium user...